Holder snapshot 6 signals
Share change
-112,677
SEC-reported price per share
$11.17
Indexed holders
32
Value change
-$81,202
Number of buys
12
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
123,305,030

Security key

N62509109

Report period

Q4 2023

Indexed institutions

32

Top holders

10

Ownership snapshot

Top reported holders of NAMS - NewAmsterdam Pharma Co N.V. - Ordinary Shares, nominal value EUR 0.12 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Frazier Life Sciences Man...
Disclosed value leader
Frazier Life Sciences Man...
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F Highest disclosed value: $113,168,904 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Frazier Life Sciences Management, L.P. has the largest disclosed position value at $113.17M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Frazier Life Sciences Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Frazier Life Sciences Management,... $113.17M
Bain Capital Life Sciences Invest... $97.07M
RA CAPITAL MANAGEMENT, L.P. $83.88M
VIKING GLOBAL INVESTORS LP $74.23M
Medicxi Ventures Management (Jers... $26.54M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Frazier Life Sciences Management, L.P.
13F
Company
13F
—
mixed-class rows
$113,168,904
12,632,038 shares
mixed-class rows
— 30 Sep 2023
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
—
mixed-class rows
$97,073,695
10,573,913 shares
mixed-class rows
— 30 Sep 2023
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
mixed-class rows
$83,883,333
9,333,333 shares
mixed-class rows
— 30 Sep 2023
VIKING GLOBAL INVESTORS LP
13F
Company
13F
—
denominator unverified
$74,227,226
8,024,565 shares
— 30 Sep 2023
Medicxi Ventures Management (Jersey) Ltd
13F
Company
13F
—
denominator unverified
$26,543,476
2,869,565 shares
— 30 Sep 2023
BVF INC/IL
13F
Company
13F
—
denominator unverified
$14,078,019
1,521,948 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
32
Shares
61,897,680
Indexed holders
32
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 indexed holders
35
Q4 2023 indexed holders
32
Indexed holder difference
-3
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .